Breast Cancer Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- A normal mammogram result within the 90 days before enrolling in the trial.
- Breasts that are classified as "heterogeneously dense" (Class C) or "extremely dense" (Class D) on a mammogram report.
- A 5-year breast cancer risk score of more than 3%, as estimated by a tool called MRS.
- Female.
- Between 25 and 55 years of age (inclusive).
- Able to understand and willing to sign a written consent form approved by an ethics review board.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- Having had more than one prior mammogram.
- Having a reason why an MRI scan with contrast dye cannot be performed, such as claustrophobia, metal objects in the body, or a known sensitivity or allergy to the contrast dye used (gadolinium).
- A personal history of breast cancer or a specific non-invasive breast condition called LCIS, or currently having either of these conditions, where that history could interfere with the trial (confirm with trial site).
- Having previously had an MRI scan used to screen the breasts.
- Being known to carry a BRCA1 or BRCA2 gene change, or any other known high-risk genetic marker for breast cancer.
- Currently taking any medication to reduce the risk of breast cancer (known as chemoprevention).
- Having breast implants.
- Currently breastfeeding.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Tabassum Ahmad, M.D., Washington University School of Medicine
Phone: 314-474-7696
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Number of successful recommendations for MRI (Feasibility portion only); 2-year detection rate (Randomized Controlled Trial only)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.